Head-to-head · WeighScore
TeleCareSpot vs telos rx
By GLP-1 ScorecardUpdated
Score comparison
telos rx has the higher recorded score — 85.4/100 to 67.7/100.
telos rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telos offers compounded oral and injectable formats; discounted plans can carry early-exit adjustments.
Before you choose
Before comparing the headline prices, the TeleCareSpot review and the telos rx review set out the plan length, renewal date and extra fees behind each semaglutide figure in the table below, and the semaglutide cost page compares published rates across the field. A lower starting price can still mean a larger bill once a longer commitment or a separate membership is added.
If neither one fits, TeleCareSpot vs Tyde Wellness and Tell Her Doc vs telos rx compare each of them with another graded program, and the list of alternatives to TeleCareSpot ranks the programs closest to TeleCareSpot on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
Of the sellers that pay us a commission, the HealthRX review covers one graded close to these two, at 77.5/100. That relationship never changes a grade, and the review lists what we could not verify.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | TeleCareSpot | telos rx |
|---|---|---|
| WeighScore | 67.7/100 | 85.4/100 |
| Grade | C | B |
| Site position | #173 | #13 |
| Semaglutide | From $299/mo (advertised; confirm consultation charge) | Advertised from $99/month injectable; plan-dependent; selected bill unverified. |
| Tirzepatide | From $399/mo (advertised; confirm consultation charge) | Advertised from $139/month injectable; from $116/month microdosed injection; selected bills unverified. |
| Coverage | Advertised exclusions: Alaska, Mississippi and New Jersey | Advertises all 50 states; pharmacy and formulation availability varies. |
| Brand-name access | Not confirmed | Not confirmed |
| Oral / sublingual | Yes | Yes |
Strengths
- Publishes starting prices for both programs
- Lists three state exclusions on its homepage
What to consider
- The homepage says a consultation fee may be applied if treatment is approved
- The general terms do not establish the selected prescription refund or renewal cutoff
Strengths
- Names its care organization and pharmacy partners
- Oral and injectable compounded options
What to consider
- Early cancellation can reprice supplied months
- Entity, denial-refund and lab terms conflict
- Current oral invoice and renewal price unverified
Featured provider
CoreAge Rx
CoreAge Rx scores 89.5/100 (B+). Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
Commercial relationships affect this placement. The score comparison above is separate.
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.